NCT07640490

Brief Summary

This study intends to conduct a prospective, double-blind, randomized, controlled trial. Adolescents aged 12-17 years old and American Society of Anesthesiologists (ASA) physical status I and II are selected as subjects. Oral probiotics is used as intervention before surgery, vital signs data, serum IL-1, IL-6, BDNF,5-HT and other inflammatory indicators are collected before surgery and after non-cardiac and non-gastrointestinal surgeries, and the incidence and degree of anxiety and depression are evaluated after non-cardiac and non-gastrointestinal surgeries. To determine the effect of esketamine on reducing anxiety and depression in adolescents after non-cardiac and non-gastrointestinal surgeries, and to provide an effective clinical basis for accelerating the rehabilitation of adolescents after non-cardiac and non-gastrointestinal surgeries.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Aug 2025

Shorter than P25 for early_phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 2, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 2, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 2, 2026

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

May 14, 2026

Completed
27 days until next milestone

First Posted

Study publicly available on registry

June 10, 2026

Completed
Last Updated

June 10, 2026

Status Verified

June 1, 2026

Enrollment Period

9 months

First QC Date

May 14, 2026

Last Update Submit

June 6, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Anxiety scale scores after surgery during 2 month

    Hamilton Anxiety Rating Scale (HAMA):The lower the score, the better the result

    2 months

  • Depression scale scores after surgery during 2 month

    Beck Depression Inventory (BDI):The lower the score, the better the result

    2 months

Study Arms (2)

Continuous oral administration of probiotics(Bifidobacterium Tetra-Strain Live Bacteria Tablets)

EXPERIMENTAL

Selincon

Drug: C Group

Take a placebo, which looks no different from a probiotic agent

PLACEBO COMPARATOR
Drug: P Group

Interventions

Continuous oral administration of probiotics

Continuous oral administration of probiotics(Bifidobacterium Tetra-Strain Live Bacteria Tablets)

Take a placebo, which looks no different from a probiotic agent

Take a placebo, which looks no different from a probiotic agent

Eligibility Criteria

Age12 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • years ≤ age ≤17 years;
  • Patients who plan to undergo elective surgery under general anesthesia, and the operation time is 1-2 hours;
  • ASA grade I-II
  • The body mass index falls within the normal range, which is 18.5 - 23.9 kg/m2.

You may not qualify if:

  • The patient has psychological disorders, including but not limited to bipolar affective disorder.
  • Eating disorder
  • No informed consent form
  • Due to certain serious diseases, one needs to take medication for a long period of time.
  • Personality disorder
  • Has undergone or needs to undergo gastrointestinal surgery
  • Have taken antibiotics or probiotics within the past 8 weeks
  • Pure vegetarian diet

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Henan Provincial People's Hospital

Zhengzhou, Henan, 450000, China

Location

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 14, 2026

First Posted

June 10, 2026

Study Start

August 2, 2025

Primary Completion

May 2, 2026

Study Completion

May 2, 2026

Last Updated

June 10, 2026

Record last verified: 2026-06

Locations